News - Page 6

Published May 18, 2016 5:18 PM

PharmaSafe PhD student Kristine Heitmann will defend her PhD thesis at the University of Bergen on 25 May. The title of her thesis is "Treatment of nausea and vomiting during pregnancy- with special focus on attitudes to and use of pharmacological treatment".

Publisert 11. mai 2016 05:51

Om NFIF gjesteforelesningen med Dr. Ross T. Tsuyuki: Hvilke roller kanadiske farmasøyter har i dag og hvordan de har jobbet for å utvikle nye offentlige pasienttjenester i apotek.

Published Mar. 31, 2016 12:10 PM

The PharmaSafe group has published another article and a book chapter in March. In addition, the scientific article was featured on and

Published Nov. 10, 2015 4:05 PM

PhD-student Richelle Vlenterie is visiting the Pharma-Safe research environment at University of Oslo to expand her knowledge, work together with people who have experience with regards to drug safety, and have access to the Norwegian Mother and Child Cohort Study (MoBa) dataset.

Published Sep. 25, 2015 9:24 AM

Guest researcher Dr. Michael Twigg visited Pharma-Safe 2 weeks in September 2015 to work on his project "Women’s beliefs about medication treatment of common conditions experienced during their pregnancy: a UK perspective."

Publisert 30. mars 2015 15:36

Social pharmacy is a small discipline with few researchers and environments in Norway. Therefore, Karin Svensberg from Pharmasafe and collages in Norway and Denmark decided to arrange a Scandinavian meeting/course in Copenhagen with PhD students primarily taking their thesis in the field of pharmaceutical policy or practice research. The aim was to network and to have informal discussions on methods and research with each other. Read more here.

Published Mar. 11, 2015 3:47 PM

A new study from the “Multinational Medication Use in Pregnancy Study” has been published. Researcher from Pharmasafe and the University of Belgrade found that the Serbian translation of the Edinburgh Postnatal Depression Scale (EPDS) showed good consistency and good model characteristics in pregnant and postpartum women. High level of depression symptoms (score ≥13) was recorded in 27.6% and 24.8% (p>0.05) of pregnant and postpartum women, respectively.

Link to paper:

Published Mar. 11, 2015 3:44 PM

Optimal treatment of psychiatric disorders during pregnancy is of utmost importance to ensure maternal-fetal health. In this study, we found that 48.8% of women demonstrated low adherence to pharmacotherapy during pregnancy. Life-style factors, risk perception, depressive symptoms and individual beliefs are important factors related to adherence to psychotropic medication in pregnancy.

Link to paper: